Cardiol Therapeutics Inc. (CRDL)
NASDAQ: CRDL · Real-Time Price · USD
1.060
0.00 (0.00%)
At close: Jun 18, 2026, 4:00 PM EDT
1.070
+0.010 (0.94%)
After-hours: Jun 18, 2026, 6:55 PM EDT
Cardiol Therapeutics Employees
Cardiol Therapeutics had 18 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
18
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,446,731
Market Cap
122.34M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 18 | 0 | - |
| Dec 31, 2024 | 18 | - | - |
| Dec 31, 2018 | 6 | - | - |
| Sep 30, 2018 | 8 | - | - |
| Jun 30, 2018 | 8 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Organigram Global | 1,120 |
| Aurora Cannabis | 1,028 |
| Lifecore Biomedical | 382 |
| Anika Therapeutics | 235 |
| Akebia Therapeutics | 194 |
| Alpha Teknova | 158 |
| Cumberland Pharmaceuticals | 93 |
| Journey Medical | 58 |
CRDL News
- 5 weeks ago - Cardiol Therapeutics to Participate in Fireside Chat at H.C. Wainwright 4th Annual BioConnect Investor Conference at the NASDAQ - PRNewsWire
- 5 weeks ago - Cardiol Therapeutics Registration statement: Q1 2026 - Filings
- 5 weeks ago - Cardiol Therapeutics Registration statement: Q1 2026 - Filings
- 5 weeks ago - Cardiol Therapeutics Slides: Corporate presentation - Filings
- 6 weeks ago - Cardiol Therapeutics' Phase II MAvERIC Results Accepted for Publication in the Journal of the American Heart Association - PRNewsWire
- 7 weeks ago - Cardiol Therapeutics (CRDL) Expands MAVERIC Trial with New Clinical Sites - GuruFocus
- 7 weeks ago - Cardiol Therapeutics expands U.S. MAVERIC Phase III trial network - TheFly
- 7 weeks ago - Cardiol Therapeutics Expands U.S. MAVERIC Phase III Trial Network to Address Growing Interest in the Pivotal Program - PRNewsWire